EARLY ADRENAL HYPOFUNCTION IN PATIENTS WITH ORGAN-SPECIFIC AUTOANTIBODIES AND NO CLINICAL ADRENAL INSUFFICIENCY

被引:33
作者
BOSCARO, M
BETTERLE, C
SONINO, N
VOLPATO, M
PAOLETTA, A
FALLO, F
机构
关键词
D O I
10.1210/jc.79.2.452
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Idiopathic Addison's disease occurs frequently in association with other organ-specific autoimmune diseases, and autoantibodies to adrenal cortex are markers of this condition. A variable asymptomatic period with subtle adrenal dysfunction may precede the onset of clinical manifestations. We studied the pituitary-adrenal axis by measuring plasma ACTH, cortisol, and 17 alpha-hydroxyprogesterone after ovine CRH (100 mu g as an iv bolus) stimulation in 19 patients with organ-specific autoimmune disease and adrenal autoantibodies, in whom adrenal steroids were normal under baseline conditions and normally responsive to a standard ACTH stimulation test (250 mu g). In all subjects, oCRH produced a normal increase in plasma ACTH. Plasma cortisol, which was normoresponsive in 11 subjects, showed little or no increase in 8 subjects. Two of these patients developed overt adrenal failure after 1 yr. The 17 alpha-hydroxyprogesterone response to oCRH, tested in 10 of 19 patients, paralleled that of plasma cortisol, excluding a steroidogenic block at the 21-hydroxylase site. Our data demonstrate the existence of a very early phase of Addison's disease in which adrenal function shows an impaired response to ovine CRH-stimulated ACTH.
引用
收藏
页码:452 / 455
页数:4
相关论文
共 34 条
[1]   STEROID 21-HYDROXYLASE IS A MAJOR AUTOANTIGEN INVOLVED IN ADULT ONSET AUTOIMMUNE ADDISONS-DISEASE [J].
BEDNAREK, J ;
FURMANIAK, J ;
WEDLOCK, N ;
KISO, Y ;
BAUMANNANTCZAK, A ;
FOWLER, S ;
KRISHNAN, H ;
CRAFT, JA ;
SMITH, BR .
FEBS LETTERS, 1992, 309 (01) :51-55
[2]   THE NATURAL-HISTORY OF ADRENAL-FUNCTION IN AUTOIMMUNE PATIENTS WITH ADRENAL AUTOANTIBODIES [J].
BETTERLE, C ;
SCALICI, C ;
PRESOTTO, F ;
PEDINI, B ;
MORO, L ;
RIGON, F ;
MANTERO, F .
JOURNAL OF ENDOCRINOLOGY, 1988, 117 (03) :467-475
[3]  
BETTERLE C, 1983, LANCET, V1, P1238
[4]   THE USE OF LOW-DOSES OF ACTH IN THE INVESTIGATION OF ADRENAL-FUNCTION IN MAN [J].
CROWLEY, S ;
HINDMARSH, PC ;
HOLOWNIA, P ;
HONOUR, JW ;
BROOK, CGD .
JOURNAL OF ENDOCRINOLOGY, 1991, 130 (03) :475-479
[5]   REMISSION OF SUBCLINICAL ADRENOCORTICAL FAILURE IN SUBJECTS WITH ADRENAL AUTOANTIBODIES [J].
DEBELLIS, A ;
BIZZARRO, A ;
ROSSI, R ;
PAGLIONICO, VA ;
CRISCUOLO, T ;
LOMBARDI, G ;
BELLASTELLA, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (04) :1002-1007
[6]  
DLUHY RG, 1974, ANN INTERN MED, V80, P693, DOI 10.7326/0003-4819-80-6-693
[7]  
EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360
[8]   KETOCONAZOLE TREATMENT OF TYPE-1 AUTOIMMUNE POLYGLANDULAR SYNDROME - EFFECTS ON PITUITARY-ADRENAL AXIS [J].
FEUILLAN, P ;
POTH, M ;
REILLY, W ;
BRIGHT, G ;
LORIAUX, DL ;
CHROUSOS, GP .
JOURNAL OF PEDIATRICS, 1986, 109 (02) :363-366
[9]   PHYSIOLOGICAL DOSING OF EXOGENOUS ACTH [J].
GRAYBEAL, ML ;
FANG, VS .
ACTA ENDOCRINOLOGICA, 1985, 108 (03) :401-406
[10]   PLASMA ADRENOCORTICOTROPIN, CORTISOL, AND ALDOSTERONE RESPONSES TO CORTICOTROPIN-RELEASING FACTOR - MODULATORY EFFECT OF BASAL CORTISOL-LEVELS [J].
HERMUS, ARMM ;
PIETERS, GFFM ;
SMALS, AGH ;
BENRAAD, TJ ;
KLOPPENBORG, PWC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1984, 58 (01) :187-191